Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,701.60
(
0.00%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
96.34
(
-4.78%
)
Bitcoin
76,674.89
(
-0.77%
)
News Focus
News Focus
Post# of 257628
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123010
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 201141

Wednesday, 05/04/2016 10:56:55 AM

Wednesday, May 04, 2016 10:56:55 AM

Post# of 257628

I can't see why Shire wouldn't want generic Humira unless they feel that with dozens of other companies involved the competitive landscape is unfavorable.

SHPG doesn't have any FoB programs, so they may decide that M923 falls outside their scope of interest.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up